Abstract
A [3 + 3] annelation of enantiomerically pure aziridine 7 provides the functionalised piperidine 8 that can be elaborated to the indolizidine skeleton in only 4 steps with good stereocontrol.
Introduction
Indolizidine alkaloids represent one of the most structurally diverse classes of natural products and have attracted considerable attention because of their varied biological activity (some examples are illustrated in Scheme 1) [1]. Recent studies in our labs have demonstrated that a range of piperidine alkaloids, [2–6] including quinolizidine based targets, [7–8] can be prepared stereoselectively through the employment of a [3 + 3] annelation strategy [9]. This approach exploits the commercially available reagent 1 developed by Trost [10] that employs a nucleophilic allylsilane motif in conjunction with an allylic acetate moiety. In an effort to expand our studies to new structural classes, we have turned our attention to the employment of this technique in the synthesis of indolizidines. Specifically, and as outlined in Scheme 1, we envisaged that a key piperidine intermediate 3 could be prepared in enantiomerically pure form and converted into a functionalised indolizidine intermediate 4 within a few steps. We wish to report herein our recent progress towards this goal.
Our studies began with the preparation of an appropriate precursor to the desired functionalised piperidine (Scheme 2). Specifically, we prepared an enantiomerically pure silyl protected aziridine 7 using a modification of the route described by Righi and co-workers [11]. Accordingly, tosyl protection of (R)-serine 5 followed by esterification and TBDPS-protection provided 6 in good overall yield. Ester reduction was carried out conveniently on multigram scale using LiBH4 to give an amino alcohol that was smoothly transformed to aziridine 7 after Mitsunobu condensation.
Having arrived at the key [3+3] annelation step, we decided to employ our standard conditions for the Pd-catalysed reaction. Indeed, we were pleased to find that the desired piperidine 8 could be furnished in high yield and that this reaction allowed 2–3 g of material to be made available at this stage (Table 1, Entry 1). Moreover, we took the opportunity to carry out a study into the role of n-BuLi in this process. Specifically, Trost described the use of this reagent as a reductant for the generation of low valent Pd required for generation of the intermediate TMM-reagent [12]. However, the ability of phosphite to carry out the reduction of Pd(II) to Pd(0) suggested to us that the annelation should proceed equally well in the absence of n-BuLi [13]. In an effort to clarify this issue we carried out a study of the [3 + 3] reaction in the absence of the alkyllithium reagent. As outlined in Table 1, Entries 2–4, the annelation was found to proceed in the absence of n-BuLi, however, in all cases the yield of cyclisation product was significantly lower than with catalyst generated by the organolithium reagent. Whilst the underlying reasons for this difference in catalyst activity are unclear at present, we speculate that n-BuLi may be responsible for the formation of hitherto uncharacterised phosphine ligands BunP(OiPr)3-n that promote the annelation over simple P(OiPr)3. Indeed, analogous alkoxide substitution reactions of phosphites have been reported using Grignard reagents [14]. In addition, 31P NMR studies showed that the addition of 1 equivalent of nBuLi to P(OPri)3 gave a mixture of P(OPri)3 and PBun3 after 15 minutes (See Supporting Information File 1 for details). Interestingly however, we have found PBun3 to be inefficient in [3 + 3] reactions as it appears to promote by-product formation [8]. Studies into the nature of the catalyst in the presence of n-BuLi are ongoing.
Table 1.
Entry | Reductant | mol% P(OiPr)3 | Yield |
1 | nBuLi | 60 | 74% |
2 | - | 60 | 38% |
3 | - | 40 | 25% |
4 | - | 80 | 11% |
With the key piperidine 8 in hand, we turned our attention to the assembly of the indolizidine skeleton. Deprotection of the silyl ether proceeded smoothly and the alcohol was oxidised to the corresponding aldehyde 9 under Swern conditions. Addition of the Li-enolate of EtOAc to the crude aldehyde provided the aldol product 10 in high yield and with good diastereocontrol (Scheme 3). Notably, reduction of 9 (NaBH4, MeOH) followed by formation of the corresponding Mosher's ester showed a single resonance in the 19F NMR spectrum (235 MHz, CDCl3: δ-72.0) suggesting that minimal epimerisation had taken place during the oxidation process.
We next decided to investigate the formation of the azabicycle via the deprotection of the Ts-amine moiety followed by cyclisation onto the ester. Previous work in the quinolizidine area had shown that these transformations could be achieved in one-pot by the use of Mg turnings in methanol at ambient temperature [7–8]. Indeed, subjecting 10 to these conditions provided the desired indolizidine 11, albeit in modest yield. Finally, acetylation of the hydroxyl group provided 12 and allowed the diastereoisomers to be separated and individually characterised (Scheme 4). Unfortunately however, we were unable to determine the product stereochemistry unequivocally in either case (the 1H NMR data for the minor diastereomer of 12 compares well with a close analogue reported by Knapp and co-workers suggesting that the aldol addition reaction proceeds under Felkin-Anh control [see Supporting Information File 1]).
In conclusion, we have shown that functionalised indolizidinone intermediates can be generated through the Pd-catalysed [3 + 3] annelation of aziridines and Trost's conjunctive allylsilane reagent. We have also found that reduction of the lactam unit of 11 and acetylation of the hydroxyl group takes place smoothly to provide 13, demonstrating the potential of these intermediates for the synthesis of slaframine and related indolizidines (Scheme 5).
Supporting Information
Acknowledgments
We thank the EPSRC and GSK for studentship funding.
Contributor Information
Olivier Y Provoost, Email: olivier.provoost@syngenta.com.
Andrew J Hazelwood, Email: andrew.j.hazelwood@gsk.com.
Joseph P A Harrity, Email: j.harrity@shef.ac.uk.
References
- 1.Takahata H, Momose T. In: The Alkaloids. Cordell G A, editor. Vol. 44. San Diego: Academic Press; 1993. Chapter 3. [Google Scholar]
- 2.Hedley S J, Moran W J, Prenzel A H G P, Price D A, Harrity J P A. Synlett. 2001:1596. doi: 10.1055/s-2001-17443. [DOI] [Google Scholar]
- 3.Hedley S J, Moran W J, Price D A, Harrity J P A. J Org Chem. 2003;68:4286. doi: 10.1021/jo030002c. [DOI] [PubMed] [Google Scholar]
- 4.Goodenough K M, Raubo P, Harrity J P A. Org Lett. 2005;7:2993. doi: 10.1021/ol050965t. [DOI] [PubMed] [Google Scholar]
- 5.Provoost O Y, Hedley S J, Hazelwood A J, Harrity J P A. Tetrahedron Lett. 2006;47:331. doi: 10.1016/j.tetlet.2005.11.015. [DOI] [Google Scholar]
- 6.Pattenden L C, Wybrow R A J, Smith S A, Harrity J P A. Org Lett. 2006;8:3089. doi: 10.1021/ol0610789. [DOI] [PubMed] [Google Scholar]
- 7.Moran W J, Goodenough K M, Raubo P, Harrity J P A. Org Lett. 2003;5:3427. doi: 10.1021/ol035156t. [DOI] [PubMed] [Google Scholar]
- 8.Goodenough K M, Moran W J, Raubo P, Harrity J P A. J Org Chem. 2005;70:207. doi: 10.1021/jo048455k. [DOI] [PubMed] [Google Scholar]
- 9.Hsung R P, Kurdyumov A V, Sydorenko N. Eur J Org Chem. 2005:23. doi: 10.1002/ejoc.200400567. [DOI] [Google Scholar]
- 10.Trost B M. Angew Chem, Int Ed Engl. 1986;25:1. doi: 10.1002/anie.198600013. [DOI] [Google Scholar]
- 11.Righi P, Scardovi N, Marotta E, ten Holte P, Zwanenburg B. Org Lett. 2002;4:497. doi: 10.1021/ol0170152. [DOI] [PubMed] [Google Scholar]
- 12.Trost B M, Nanninga T N. J Am Chem Soc. 1985;107:1293. doi: 10.1021/ja00291a032. [DOI] [Google Scholar]
- 13.Trost B M, Renaut P. J Am Chem Soc. 1982;104:6668. doi: 10.1021/ja00388a032. [DOI] [Google Scholar]
- 14.Berlin K D, Austin T H, Stone K L. J Am Chem Soc. 1964;86:1787. doi: 10.1021/ja01063a027. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.